Diana Hausman
2020 - Zymeworks
In 2020, Diana Hausman earned a total compensation of $1.9M as Former Chief Medical Officer at Zymeworks, a 38% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $166,480 |
|---|---|
| Option Awards | $1,033,233 |
| Salary | $449,946 |
| Stock Awards | $264,000 |
| Other | $20,188 |
| Total | $1,933,847 |
Hausman received $1M in option awards, accounting for 53% of the total pay in 2020.
Hausman also received $166.5K in non-equity incentive plan, $449.9K in salary, $264K in stock awards and $20.2K in other compensation.
Rankings
In 2020, Diana Hausman's compensation ranked 5,668th out of 13,090 executives tracked by ExecPay. In other words, Hausman earned more than 56.7% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 5,668 out of 13,090 | 57th |
Division Manufacturing | 2,343 out of 5,621 | 58th |
Major group Chemicals And Allied Products | 937 out of 2,254 | 58th |
Industry group Drugs | 811 out of 1,954 | 59th |
Industry Pharmaceutical Preparations | 603 out of 1,459 | 59th |
Source: SEC filing on November 25, 2022.
Hausman's colleagues
We found three more compensation records of executives who worked with Diana Hausman at Zymeworks in 2020.